ZAKA VC — 2025 Investments
1 investments dated 2025 · listed companies and verified rows first · show all
Nephrogennephrogenbiotech.comin𝕏Nov 2025
Nephrogen develops AI-powered AAV delivery vehicles for genetic medicines targeting kidney and pancreatic diseases.
AI & Machine LearningBiotechData & InfrastructureHealthtechMedical DevicesNew York City, US
Demetri Maxim(Founder and CEO)Vivek Bhalla(Chief Medical Officer)
Co-investorsTechstarsY Combinator
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.